Subtype-selective prenylated isoflavonoids disrupt regulatory drivers of MYCN-amplified cancers.
Stokes ME, Vasciaveo A, Small JC, Zask A, Reznik E, Smith N, Wang Q, Daniels J, Forouhar F, Rajbhandari P, Califano A, Stockwell BR.
Stokes ME, et al. Among authors: small jc.
Cell Chem Biol. 2024 Apr 18;31(4):805-819.e9. doi: 10.1016/j.chembiol.2023.11.007. Epub 2023 Dec 6.
Cell Chem Biol. 2024.
PMID: 38061356